94 related articles for article (PubMed ID: 31261293)
1. Can Virtual Contrast Enhancement in Brain MRI Replace Gadolinium?: A Feasibility Study.
Kleesiek J; Morshuis JN; Isensee F; Deike-Hofmann K; Paech D; Kickingereder P; Köthe U; Rother C; Forsting M; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2019 Oct; 54(10):653-660. PubMed ID: 31261293
[TBL] [Abstract][Full Text] [Related]
2. Brain Tumor Imaging without Gadolinium-based Contrast Agents: Feasible or Fantasy?
Wamelink IJHG; Azizova A; Booth TC; Mutsaerts HJMM; Ogunleye A; Mankad K; Petr J; Barkhof F; Keil VC
Radiology; 2024 Feb; 310(2):e230793. PubMed ID: 38319162
[TBL] [Abstract][Full Text] [Related]
3. Automatic Active Lesion Tracking in Multiple Sclerosis Using Unsupervised Machine Learning.
Uwaeze J; Narayana PA; Kamali A; Braverman V; Jacobs MA; Akhbardeh A
Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535052
[TBL] [Abstract][Full Text] [Related]
4. Pixelwise Gradient Model with GAN for Virtual Contrast Enhancement in MRI Imaging.
Cheng KH; Li W; Lee FK; Li T; Cai J
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473363
[No Abstract] [Full Text] [Related]
5. MRI gadolinium dosing on basis of blood volume.
Liu CY; Lai S; Lima JAC
Magn Reson Med; 2019 Feb; 81(2):1157-1164. PubMed ID: 30387903
[TBL] [Abstract][Full Text] [Related]
6. The feasibility of half-dose contrast-enhanced scanning of brain tumours at 5.0 T: a preliminary study.
Jiang Z; Sun W; Xu D; Mei H; Yuan J; Song X; Ma C; Xu H
BMC Med Imaging; 2024 Apr; 24(1):88. PubMed ID: 38615005
[TBL] [Abstract][Full Text] [Related]
7. A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.
Xue X; Bo R; Qu H; Jia B; Xiao W; Yuan Y; Vapniarsky N; Lindstrom A; Wu H; Zhang D; Li L; Ricci M; Ma Z; Zhu Z; Lin TY; Louie AY; Li Y
Biomaterials; 2020 Oct; 257():120234. PubMed ID: 32736259
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement.
Bobholz SA; Lowman AK; Connelly JM; Duenweg SR; Winiarz A; Nath B; Kyereme F; Brehler M; Bukowy J; Coss D; Lupo JM; Phillips JJ; Ellingson BM; Krucoff MO; Mueller WM; Banerjee A; LaViolette PS
Neurosurgery; 2024 Mar; ():. PubMed ID: 38501824
[TBL] [Abstract][Full Text] [Related]
9. Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.
Nelson SJ
NMR Biomed; 2011 Jul; 24(6):734-49. PubMed ID: 21538632
[TBL] [Abstract][Full Text] [Related]
10. An update on susceptibility-weighted imaging in brain gliomas.
Martín-Noguerol T; Santos-Armentia E; Ramos A; Luna A
Eur Radiol; 2024 Apr; ():. PubMed ID: 38581609
[TBL] [Abstract][Full Text] [Related]
11. Quantifying gadolinium-based nanoparticle uptake distributions in brain metastases via magnetic resonance imaging.
Bennett S; Verry C; Kaza E; Miao X; Dufort S; Boux F; Crémillieux Y; de Beaumont O; Le Duc G; Berbeco R; Sudhyadhom A
Sci Rep; 2024 May; 14(1):11959. PubMed ID: 38796495
[TBL] [Abstract][Full Text] [Related]
12. Comparative Evaluation of Lower Gadolinium Doses for MR Imaging of Meningiomas: How Low Can We Go?
Dowers T; Helmi A; Mbanwi AN; Alcaide-Leon P
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38858096
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice.
Bhargava R; Hahn G; Hirsch W; Kim MJ; Mentzel HJ; Olsen OE; Stokland E; Triulzi F; Vazquez E
Magn Reson Insights; 2013; 6():95-111. PubMed ID: 25114547
[TBL] [Abstract][Full Text] [Related]
14. Predicting brain age using partition modeling strategy and atlas-based attentional enhancement in the Chinese population.
Wu Y; Chen Y; Yang Y; Lin C; Su S; Zhao J; Wu S; Wu G; Liu H; Liu X; Yang Z; Zhang J; Huang B
Cereb Cortex; 2024 Jan; 34(2):. PubMed ID: 38342684
[TBL] [Abstract][Full Text] [Related]
15. Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study.
Ammari S; Bône A; Balleyguier C; Moulton E; Chouzenoux É; Volk A; Menu Y; Bidault F; Nicolas F; Robert P; Rohé MM; Lassau N
Invest Radiol; 2022 Feb; 57(2):99-107. PubMed ID: 34324463
[TBL] [Abstract][Full Text] [Related]
16. A generic deep learning model for reduced gadolinium dose in contrast-enhanced brain MRI.
Pasumarthi S; Tamir JI; Christensen S; Zaharchuk G; Zhang T; Gong E
Magn Reson Med; 2021 Sep; 86(3):1687-1700. PubMed ID: 33914965
[TBL] [Abstract][Full Text] [Related]
17. Virtual Contrast-Enhanced Magnetic Resonance Images Synthesis for Patients With Nasopharyngeal Carcinoma Using Multimodality-Guided Synergistic Neural Network.
Li W; Xiao H; Li T; Ren G; Lam S; Teng X; Liu C; Zhang J; Kar-Ho Lee F; Au KH; Ho-Fun Lee V; Chang ATY; Cai J
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):1033-1044. PubMed ID: 34774997
[TBL] [Abstract][Full Text] [Related]
18. Time conditioning for arbitrary contrast phase generation in interventional computed tomography.
Pinnock MA; Hu Y; Bandula S; Barratt DC
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38697200
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced to non-contrast-enhanced image translation to exploit a clinical data warehouse of T1-weighted brain MRI.
Bottani S; Thibeau-Sutre E; Maire A; Ströer S; Dormont D; Colliot O; Burgos N;
BMC Med Imaging; 2024 Mar; 24(1):67. PubMed ID: 38504179
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
